Changes in Properties of Serine 129 Phosphorylated α-Synuclein with Progression of Lewy Type Histopathology in Human Brains
Experimental Neurology; Volume 240, February 2013, Pages 190–204; doi 10.1016/j.expneurol.2012.11.020.
Critique of the use of fluorescence-based reporters in Escherichia coli as a screening tool for the identification of peptide inhibitors of Aβ42 aggregation
J. Peptide Sci; doi: 10.1002/psc.2474
Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity
Molecular Genetics and Metabolism; 2013 Jan;108(1):56-64, ISSN 1096-7192, DOI 10.1016/j.ymgme.2012.11.010.
Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicity
Int Immunopharmacol; 2012 Sep 28. doi: 10.1016/j.intimp.2012.09.007..
Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening
J Biol Chem.; DOI: 10.1074/jbc.M112.379792
Lowered Serum Amyloid-β1-42 Autoantibodies in Individuals with Lifetime Depression
Journal of Alzheimer’s Disease; 2012 Jul 5. DOI: 10.3233/JAD-2012-120625
Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis
FEBS Letters (2012), doi:10.1016/j.febslet.2012.06.040
A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo.
Neurotherapeutics; Volume 9, Number 2, 464-476, DOI: 10.1007/s13311-012-0105-1.
New evidence on α-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders
J Pharm Bioallied Sci.; 2012 Apr-Jun; 4(2): 112–117. doi: 10.4103/0975-7406.9481; PMCID: PMC3341714
An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology
Acta Neuropathologica; 2012, DOI: 10.1007/s00401-012-0964-x.